Dr. Cowey, MD
Claim this profileTexas Oncology - Baylor Charles A. Sammons Cancer Center
Studies Squamous Cell Carcinoma
Studies Head and Neck Cancers
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Cowey, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Cowey, MD has experience with
- CyPep-1
- Pembrolizumab
Breakdown of trials Cowey, MD has run
Squamous Cell Carcinoma
Head and Neck Cancers
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cowey, MD specialize in?
Cowey, MD focuses on Squamous Cell Carcinoma and Head and Neck Cancers. In particular, much of their work with Squamous Cell Carcinoma has involved treating patients, or patients who are undergoing treatment.
Is Cowey, MD currently recruiting for clinical trials?
No, Cowey, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Cowey, MD has studied deeply?
Yes, Cowey, MD has studied treatments such as CyPep-1, Pembrolizumab.
What is the best way to schedule an appointment with Cowey, MD?
Apply for one of the trials that Cowey, MD is conducting.
What is the office address of Cowey, MD?
The office of Cowey, MD is located at: Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology - Baylor Charles A. Sammons Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.